Literature DB >> 20399631

Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD.

Alastair J Moore1, Rosa Suades Soler, Edward J Cetti, S Amanda Sathyapala, Nicholas S Hopkinson, Michael Roughton, John Moxham, Michael I Polkey.   

Abstract

BACKGROUND: Hyperinflation is a recognized adverse prognostic factor in COPD. As the sniff inspiratory nasal pressure (SnIP) principally reflects the severity of hyperinflation in COPD, we hypothesized that it might also be a predictor of mortality. We therefore compared the SnIP to the inspiratory capacity-to-total lung capacity (IC/TLC) ratio as predictors of mortality in advanced COPD.
METHODS: A retrospective mortality analysis of 110 patients with COPD (mean FEV(1) 1.01litres, 37% predicted; 66% male) was performed. All patients had SnIP and lung volume measurements performed. The power of each test to predict mortality was determined, and predicted survival curves were created for both the SnIP and IC/TLC ratio.
RESULTS: 37 patients (34%) died during the study period (29 male, 8 female). Mortality rates were analysed with a Chi(2) test; there was a significant trend towards male death (mortality rate male vs. female; 39.7% vs. 21.6% respectively; chi(2)p=0.058, Chi 3.6). ROC curves demonstrated that both SnIP and IC/TLC ratio are predictors of mortality, but analysis by Cox proportional hazards suggested the SnIP has a stronger predictive power (SnIP vs. IC/TLC ratio; p=0.017 vs 0.525; HR 0.97 vs 0.99 respectively), and analysis of the area under ROC curves (AUC) suggest that SnIP is a better discriminator than IC/TLC ratio (AUC SnIP vs IC/TLC; 0.679 vs 0.618).
CONCLUSIONS: The SnIP conveys at least as much predictive power for mortality in COPD as hyperinflation determined by IC/TLC ratio. This test is cheaper, quicker and easier than measuring lung volumes by plethysmography.

Entities:  

Mesh:

Year:  2010        PMID: 20399631     DOI: 10.1016/j.rmed.2010.03.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

1.  Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD.

Authors:  Leila Donária; Rafael Mesquita; Larissa Martinez; Luciana Sípoli; Josiane Marques Felcar; Vanessa Suziane Probst; Nidia Aparecida Hernandes; Fabio Pitta
Journal:  Lung       Date:  2014-10-01       Impact factor: 2.584

2.  Patent foramen ovale is not associated with hypoxemia in severe chronic obstructive pulmonary disease and does not impair exercise performance.

Authors:  Zarrin F Shaikh; Julia L Kelly; Dinesh Shrikrishna; Manuel de Villa; Michael J Mullen; Nicholas S Hopkinson; Mary J Morrell; Michael I Polkey
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

Review 3.  Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Authors:  Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-07       Impact factor: 2.871

4.  A combined pulmonary function and emphysema score prognostic index for staging in Chronic Obstructive Pulmonary Disease.

Authors:  Afroditi K Boutou; Arjun Nair; Dariush Douraghi-Zadeh; Ranbir Sandhu; David M Hansell; Athol U Wells; Michael I Polkey; Nicholas S Hopkinson
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

5.  Sniff nasal inspiratory pressure does not decrease in elderly subjects.

Authors:  Chien-Hui Huang; Gee-Gwo Yang; Tung-Wei Chen
Journal:  J Phys Ther Sci       Date:  2014-09-17

6.  Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.

Authors:  Jilles M Fermont; Katya L Masconi; Magnus T Jensen; Renata Ferrari; Valéria A P Di Lorenzo; Jacob M Marott; Philipp Schuetz; Henrik Watz; Benjamin Waschki; Hana Müllerova; Michael I Polkey; Ian B Wilkinson; Angela M Wood
Journal:  Thorax       Date:  2019-01-07       Impact factor: 9.139

7.  Lung function indices for predicting mortality in COPD.

Authors:  Afroditi K Boutou; Dinesh Shrikrishna; Rebecca J Tanner; Cayley Smith; Julia L Kelly; Simon P Ward; Michael I Polkey; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2013-01-24       Impact factor: 16.671

8.  Effects of diaphragmatic control on the assessment of sniff nasal inspiratory pressure and maximum relaxation rate.

Authors:  Kadja Benício; Fernando A L Dias; Lucien P Gualdi; Andrea Aliverti; Vanessa R Resqueti; Guilherme A F Fregonezi
Journal:  Braz J Phys Ther       Date:  2015-11-17       Impact factor: 3.377

9.  Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Wouter H van Geffen; Huib Am Kerstjens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-18

10.  Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme.

Authors:  Sara C Buttery; Adam Lewis; Samuel V Kemp; Winston Banya; Jennifer K Quint; Michael C Steiner; Nicholas S Hopkinson
Journal:  BMJ Open       Date:  2020-11-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.